Beth Israel Medical Center

Details

Name :

Beth Israel Medical Center

Address  :

First Avenue at 16th Street

Town  :

New York

State  :

New York

Country  :

USA

Post Code:

NY 10003

Phone  :

212 420 2000

Web URL  :

Specialization
  • Anaesthesiology
  • Cardiology
  • Colon & Rectal Surgeon
  • Daibetes, Endocrinology
  • Dentistry
  • Dermatology
  • ENT
  • Gastro-enterology
  • General Surgeon
  • Gynaecology
  • Internal Medicine
  • Maxillofacial Surgery
  • Neuro Surgeon
  • Neurologist
  • Obestetrician/Gynecologist
  • Oncologist
  • Ophthalmology
  • Orthopedics
  • Otolaryngologist
  • Paediatrics
  • Pain Management
  • Pathology Lab
  • Plastic Surgery
  • Podiatry
  • Pulmonology
  • Urology
  • Vascular Surgeon
Facilities

Total Number Of Beds : 799


Description

Beth Israel Medical Center is excited to be at the forefront of medicine with the latest technology and innovations

Our growth in the last two years has been unprecedented and we continue to grow The renovations of our Emergency Department and many inpatient units are focused on providing you with a better patient experience

Some highlights include the opening of The Friedman Diabetes Institute which focuses on the lifestyle of the diabetic patient to ensure lasting medical success the increase in the number of accessible interpreters and special navigator programs to ease cultural barriers for our Jewish Chinese and Russian patients and the opening of The Chris and Morton P Hyman Patient Care Unit which features amenities similar to fivestar hotels
Hospital checklists cut readmissions Medicare costs

In another win for inhospital checklists new research finds that a simple onepage checklist can keep heart patients out of the hospital as well as save Medicare billions of dollars according to a presentation Saturday at the American College of Cardiologys ACC annual scientific session After using the 27question checklist before discharge 30day ... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More